Cite Filings / TPST / 0001193125-22-136738

Feed Companies Filings Check

Sign in

DEF 14A

Proxy Statement

Tempest Therapeutics, Inc. Filed 2022-05-02 Acc 0001193125-22-136738

Documents 1

DEF 14A Proxy Statement , d342375ddef14a.htm

Around this filing

2023-05-01 DEF 14A Proxy Statement
2022-05-03 4 Director bought 2,118,644 shares at $2.36 ($5,000,000)
2022-05-03 3 Initial Statement of Ownership
2022-05-02 DEFA14A Proxy Materials
2022-05-02 DEF 14A Proxy Statement
2022-05-02 8-K Material agreement · Unregistered share sale · Other events
2020-04-24 DEF 14A Proxy Statement

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading d342375ddef14a.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…